Oxford vaccine capable of boosting immunity

Dhaka, Bangladesh || Friday, 26 April 2024 || 12 Boishakh 1431

HEADLINE:

Kazi Zarzees bin Ertaza steps to 21 today Bashundhara MD honoured with ‘TRAB Smart Performance Award’ Today 20th death anniversary of Shahidur Rahman, the bright star of Judiciary President appoints Sheikh Hasina as Prime Minister First woman barrister on Board of Directors of Gulshan Club Bangladesh Army and Canadian University of Bangladesh Sign Memorandum of Understanding DNCC, Borak Real Estate sign deal, Sheraton goes into full swing

From pandemic to Padma bridge: Will the anti-Hasina brigade ever learn?

The anti-Sheikh Hasina brigade has been paid back fair

No one remembers the bravery of Badruzzamanan in '71

Badruzzaman Badrul, the expatriate son of a brave martyr

'Minar-e Kabir', the highest Islamic Monument in Jhalokati

Minar-e Kabir is a minaret located in Sugandia village

Bashundhara Group gets ‘Best Brand’ recognition

Bashundhara Group, the country’s largest business conglomerate, has been

http://www.dailyvorerpata.com/ad/72890.jpg

Oxford vaccine capable of boosting immunity

Published : Monday, 20 July, 2020 at 10:23 PM, Count : 402

Oxford vaccine capable of boosting immunity

The Oxford-made COVID-19 vaccine has been shown to be effective in preventing the deadly coronavirus. After a long three-month clinical trial, it was found to be effective in the human body. The vaccine called ChAdOx1 nCoV-19.

According to the BBC, the Lancet quoted a subgroup of ten participants as saying that in the first and second phases of the clinical trial, 1,077 candidates were injected with Oxford’s vaccine. The results showed that up to 56 days of testing, strong antibody production, and T-cell immunity were developed. This result may be more after the second dose.

Meanwhile, the researchers said that the information obtained from the clinical trial of the vaccine is much more promising. But now is not the time to say whether it will provide adequate protection. Because big tests are going on.

Oxford in UK and Moderna in US are staying ahead among 200 vaccine inventions around the world. The World Health Organization also says that Oxford is at the forefront of vaccine development. The United Kingdom has already confirmed 100 million doses of the vaccine.

The trial of the Oxford made vaccine began last April. The vaccine was first injected into the two human bodies. One of them was Dr. Elisa Granato, a microbiologist at the University of Oxford. Later in the first stage, a few numbers of human bodies were tested.

In the second phase, the vaccine was administered to more than a thousand volunteers. According to the British media, the reports of these two stages of the trial were positive. Oxford conducted the third phase trial based on the reports of the first and second phase trials. The effects of the vaccine have also been claimed to be satisfactory in trials at this stage.

Is it safe?

Yes, but there are side-effects. There were no dangerous side-effects from taking the vaccine, however, 70% of people on the trial developed either fever or headache. The researchers say this could be managed with paracetamol.

“There is still much work to be done before we can confirm if our vaccine will help manage the Covid-19 pandemic, but these early results hold promise,” said Prof Sarah Gilbert, form the University of Oxford

« Previous